Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study

Multiple Doses ◽

Dose Escalating

A first in human study to investigate the safety, tolerability and pharmacokinetics of single and multiple doses of SMT19969 in male healthy subjects

http://isrctn.org/> ◽

10.1186/isrctn10858225 ◽

2014 ◽

Author(s):

Joseph Chiesa

Keyword(s):

Healthy Subjects ◽

Human Study ◽

A First-in-Human Study of Single and Multiple Doses of anle138b in Healthy Subjects

Case Medical Research ◽

10.31525/ct1-nct04208152 ◽

2019 ◽

Author(s):

Keyword(s):

Healthy Subjects ◽

Human Study ◽

The comparative effects of single and multiple doses of RS-8359, moclobemide and placebo on psychomotor function in healthy subjects

European Neuropsychopharmacology ◽

10.1016/0924-977x(96)83010-0 ◽

1996 ◽

Vol 6 ◽

pp. S4-65-S4-66

Author(s):

K. Puechler ◽

K. Schaffler ◽

C.-H. Wauschkuhn ◽

A. Plenker

Keyword(s):

Healthy Subjects ◽

Psychomotor Function ◽

Pharmacokinetics of Single and Multiple Doses of Omega‐3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open‐Label Study

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.800 ◽

2020 ◽

Vol 9 (8) ◽

pp. 985-994

Author(s):

Shan Jing ◽

Zhenxian Zhang ◽

Xiaowen Chen ◽

Rui Miao ◽

Catarina Nilsson ◽

...

Keyword(s):

Phase I ◽

Carboxylic Acids ◽

Omega 3 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Multiple Doses ◽

Healthy Chinese ◽

Chinese Subjects

Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once‐Weekly Dipeptidyl Peptidase‐4 (DPP‐4) Inhibitor, After Single and Multiple Doses in Healthy Subjects

The Journal of Clinical Pharmacology ◽

10.1002/jcph.773 ◽

2016 ◽

Vol 56 (12) ◽

pp. 1528-1537 ◽

Cited By ~ 16

Author(s):

Rajesh Krishna ◽

Carol Addy ◽

Daniel Tatosian ◽

Xiaoli S. Glasgow ◽

Isaias Noel Gendrano III ◽

...

Keyword(s):

Healthy Subjects ◽

Dipeptidyl Peptidase ◽

Pharmacokinetics And Pharmacodynamics ◽

Dipeptidyl Peptidase 4 ◽

Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: A randomized, open-label, crossover study

Clinical Therapeutics ◽

10.1016/j.clinthera.2010.11.009 ◽

2010 ◽

Vol 32 (12) ◽

pp. 2074-2087 ◽

Cited By ~ 23

Author(s):

Mona Darwish ◽

Mary Kirby ◽

Denise M. D’Andrea ◽

Ronghua Yang ◽

Edward T. Hellriegel ◽

...

Keyword(s):

Obstructive Sleep Apnea ◽

Sleep Apnea ◽

Crossover Study ◽

Open Label ◽

Excessive Sleepiness ◽

Multiple Doses ◽

Obstructive Sleep

The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects

Clinical Drug Investigation ◽

10.1007/s40261-017-0513-4 ◽

2017 ◽

Vol 37 (7) ◽

pp. 659-667 ◽

Cited By ~ 28

Author(s):

Ka Lai Yee ◽

Sauzanne G. Khalilieh ◽

Rosa I. Sanchez ◽

Rachael Liu ◽

Matt S. Anderson ◽

...

Keyword(s):

Healthy Subjects ◽

Pharmacokinetics of single and multiple doses of flusoxolol (Ro 31-1411) in healthy subjects

European Journal of Clinical Pharmacology ◽

10.1007/bf00870998 ◽

1986 ◽

Vol 31 (1) ◽

pp. 113-115

Author(s):

H. C. Gillies ◽

H. J. Rogers ◽

R. J. Francis ◽

D. B. Galloway ◽

J. E. Humphreys

Keyword(s):

Healthy Subjects ◽

Pharmacokinetics and pharmacodynamics of single and multiple doses of the MAO-6 inhibitor lazabemide in healthy subjects

British Journal of Clinical Pharmacology ◽

10.1111/j.1365-2125.1997.tb00136.x ◽

1997 ◽

Vol 43 (1) ◽

pp. 41-47

Author(s):

Jasper Dingemanse ◽

Nolan Wood ◽

Karin Jorga ◽

Rolf Kettler

Keyword(s):

Healthy Subjects ◽

Pharmacokinetics And Pharmacodynamics ◽

Pharmacokinetics of phenylbutazone in healthy subjects after oral administration of single and multiple doses

Journal of Pharmaceutical Sciences ◽

10.1002/jps.2600691216 ◽

1980 ◽

Vol 69 (12) ◽

pp. 1413-1416 ◽

Cited By ~ 8

Author(s):

A. Sioufi ◽

D. Colussi ◽

F. Caudal ◽

J.P. Schoeller ◽

P. Massias

Keyword(s):

Oral Administration ◽

Healthy Subjects ◽